NM_001845.6:c.469-127C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.469-127C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0837 in 850,754 control chromosomes in the GnomAD database, including 3,429 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 995 hom., cov: 32)
Exomes 𝑓: 0.079 ( 2434 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0180

Publications

2 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 13-110210339-G-A is Benign according to our data. Variant chr13-110210339-G-A is described in ClinVar as Benign. ClinVar VariationId is 1262395.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.177 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.469-127C>T intron_variant Intron 8 of 51 ENST00000375820.10 NP_001836.3
COL4A1NM_001303110.2 linkc.469-127C>T intron_variant Intron 8 of 24 NP_001290039.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.469-127C>T intron_variant Intron 8 of 51 1 NM_001845.6 ENSP00000364979.4 P02462-1

Frequencies

GnomAD3 genomes
AF:
0.105
AC:
15985
AN:
151916
Hom.:
993
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.180
Gnomad AMI
AF:
0.0570
Gnomad AMR
AF:
0.0724
Gnomad ASJ
AF:
0.0467
Gnomad EAS
AF:
0.0780
Gnomad SAS
AF:
0.0778
Gnomad FIN
AF:
0.0644
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.0812
Gnomad OTH
AF:
0.0990
GnomAD4 exome
AF:
0.0791
AC:
55237
AN:
698720
Hom.:
2434
AF XY:
0.0791
AC XY:
29148
AN XY:
368532
show subpopulations
African (AFR)
AF:
0.188
AC:
3383
AN:
18020
American (AMR)
AF:
0.0615
AC:
2114
AN:
34350
Ashkenazi Jewish (ASJ)
AF:
0.0451
AC:
927
AN:
20534
East Asian (EAS)
AF:
0.0736
AC:
2408
AN:
32696
South Asian (SAS)
AF:
0.0768
AC:
4936
AN:
64230
European-Finnish (FIN)
AF:
0.0736
AC:
3062
AN:
41620
Middle Eastern (MID)
AF:
0.0377
AC:
104
AN:
2760
European-Non Finnish (NFE)
AF:
0.0787
AC:
35380
AN:
449452
Other (OTH)
AF:
0.0834
AC:
2923
AN:
35058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
2764
5529
8293
11058
13822
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
690
1380
2070
2760
3450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.105
AC:
16013
AN:
152034
Hom.:
995
Cov.:
32
AF XY:
0.103
AC XY:
7646
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.181
AC:
7485
AN:
41442
American (AMR)
AF:
0.0724
AC:
1106
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0467
AC:
162
AN:
3466
East Asian (EAS)
AF:
0.0782
AC:
404
AN:
5168
South Asian (SAS)
AF:
0.0772
AC:
372
AN:
4816
European-Finnish (FIN)
AF:
0.0644
AC:
681
AN:
10582
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0812
AC:
5519
AN:
67956
Other (OTH)
AF:
0.0985
AC:
208
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
723
1445
2168
2890
3613
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.119
Hom.:
489
Bravo
AF:
0.110
Asia WGS
AF:
0.0900
AC:
311
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
4.9
DANN
Benign
0.56
PhyloP100
-0.018
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2166208; hg19: chr13-110862686; API